Vaccines

Vaccines have arguably saved more lives and prevented more diseases than any other class of drug. The American College of Obstetricians and Gynecologists states that vaccination before conception is preferred to vaccination during pregnancy, but the benefits of immunization to the pregnant woman usually outweigh the theoretical risks (Committee Opinion, No. 282, January 2003). Only vaccines recommended for adults of reproductive age are discussed here.

Vaccines are classified as bacterial or viral; whole (killed, inactivated, or live attenuated); or partial microorganisms that can induce antibody formation. Although vaccines can cause infections of the embryo or fetus, and pregnant women should be informed of the presence of live organisms if they are given a live attenuated virus vaccine, there is no convincing evidence that any vaccine, bacterial or viral, has caused fetal or embryonic harm. Theoretically, however, live attenuated bacterial or viral vaccines could cause disseminated infection in pregnant patients with impaired immunity, such as those with HIV or AIDS.

Indications for two bacterial vaccines (both capsular polysaccharide-quadrivalent meningococcal and polyvalent pneumococcal) are not altered by pregnancy. Vaccinating a pregnant woman with the live attenuated BCG vaccine is not recommended, but may be indicated if the woman works in a setting where many patients are infected with resistant strains of TB.

There are two typhoid vaccines available. The oral live attenuated virus vaccine is not advised during pregnancy, except when the mother's in continued, close exposure or travels to typhoid-endemic areas. The capsular polysaccharide intramuscular vaccine should be safer in pregnancy because it does not contain live bacteria.

Live attenuated virus vaccines are normally contraindicated in pregnant women because of the known or potential risks from the wild viruses. These include influenza intranasal, measles, mumps, rubella, smallpox, varicella, and yellow fever. Vaccinating in the postpartum period or avoiding conception for at least 30 days after inoculation are two strategies to avoid exposure during pregnancy.

A live attenuated virus vaccine may be indicated in pregnancy under special circumstances. For example, because the risk of fetal vaccinia is low, smallpox vaccine is recommended for pregnant women exposed to smallpox or monkeypox. Yellow fever vaccine also should be given in pregnancy if exposure is unavoidable.

Rubella infection early in gestation causes congenital rubella syndrome. Over a 10-year period, nearly 700 pregnant women were given rubella vaccine. There was no evidence of embryonic/fetal adverse effects, but subclinical infection was found in 2% of the infants from susceptible mothers. A woman given the vaccine 3 weeks after conception had documented embryonic/fetal infection throughout gestation but still delivered a healthy infant.

Though contraindicated, varicella vaccine may present less risk to the embryo and fetus than from infection with the wild virus. In a pregnancy registry of more than 800 women who had been vaccinated within 3 months of or anytime during pregnancy, there was no evidence of congenital varicella syndrome (CVS) or mal- formations consistent with it.

Inactivated poliovirus vaccine is not routinely recommended for adults living in the United States; however, it is recommended for unimmunized adults in close contact with a child receiving oral polio vaccine (OPV, which is not available in United States) or who have an increased risk of exposure to OPV or wild poliovirus. Hepatitis A (inactivated) and hepatitis B (recombinant surface antigen) vaccines can be used in pregnancy for pre- and postexposure in women at risk of infection.

The indications for rabies vaccine (killed virus) are not altered by pregnancy. There also seems to be no increased risk to the embryo or fetus from vaccination within 30 days of conception with quadrivalent human papillomavirus (HPV) recombinant vaccine. But if pregnancy is detected, ACOG suggests delaying completion of the three-dose vaccination schedule until after the pregnancy (Committee Opinion, No. 344, September 2006).

The ACOGconsiders vaccination with inactivated influenza vaccine to be an essential element of prenatal care (Committee Opinion, No. 305, November 2004). The vaccine can be given at any time during pregnancy, but the intranasal influenza vaccine, a live attenuated virus preparation, should not be used in pregnancy.

Excretion of live viruses from vaccines into breast milk may occur. There is a report of tertiary contact vaccinia transmission for smallpox vaccine from a mother to her nursing infant. The effects of the other live virus vaccines on a nursing infant are unknown, but the risk of adverse effects seems to be low. Vaccines that do not contain live viruses probably carry no risk to the infant.

There are pregnancy registries for four vaccines. Health care professionals should report exposures of pregnant women to the appropriate registry: hepatitis B vaccine (800-670-6126); HPV vaccine (800-986-8999); meningococcal vaccine (800-822-2463); and varicella vaccine (800-986-8999).

Vaccines have arguably saved more lives and prevented more diseases than any other class of drug. The American College of Obstetricians and Gynecologists states that vaccination before conception is preferred to vaccination during pregnancy, but the benefits of immunization to the pregnant woman usually outweigh the theoretical risks (Committee Opinion, No. 282, January 2003). Only vaccines recommended for adults of reproductive age are discussed here.

Vaccines are classified as bacterial or viral; whole (killed, inactivated, or live attenuated); or partial microorganisms that can induce antibody formation. Although vaccines can cause infections of the embryo or fetus, and pregnant women should be informed of the presence of live organisms if they are given a live attenuated virus vaccine, there is no convincing evidence that any vaccine, bacterial or viral, has caused fetal or embryonic harm. Theoretically, however, live attenuated bacterial or viral vaccines could cause disseminated infection in pregnant patients with impaired immunity, such as those with HIV or AIDS.

Indications for two bacterial vaccines (both capsular polysaccharide-quadrivalent meningococcal and polyvalent pneumococcal) are not altered by pregnancy. Vaccinating a pregnant woman with the live attenuated BCG vaccine is not recommended, but may be indicated if the woman works in a setting where many patients are infected with resistant strains of TB.

There are two typhoid vaccines available. The oral live attenuated virus vaccine is not advised during pregnancy, except when the mother's in continued, close exposure or travels to typhoid-endemic areas. The capsular polysaccharide intramuscular vaccine should be safer in pregnancy because it does not contain live bacteria.

Live attenuated virus vaccines are normally contraindicated in pregnant women because of the known or potential risks from the wild viruses. These include influenza intranasal, measles, mumps, rubella, smallpox, varicella, and yellow fever. Vaccinating in the postpartum period or avoiding conception for at least 30 days after inoculation are two strategies to avoid exposure during pregnancy.

A live attenuated virus vaccine may be indicated in pregnancy under special circumstances. For example, because the risk of fetal vaccinia is low, smallpox vaccine is recommended for pregnant women exposed to smallpox or monkeypox. Yellow fever vaccine also should be given in pregnancy if exposure is unavoidable.

Rubella infection early in gestation causes congenital rubella syndrome. Over a 10-year period, nearly 700 pregnant women were given rubella vaccine. There was no evidence of embryonic/fetal adverse effects, but subclinical infection was found in 2% of the infants from susceptible mothers. A woman given the vaccine 3 weeks after conception had documented embryonic/fetal infection throughout gestation but still delivered a healthy infant.

Though contraindicated, varicella vaccine may present less risk to the embryo and fetus than from infection with the wild virus. In a pregnancy registry of more than 800 women who had been vaccinated within 3 months of or anytime during pregnancy, there was no evidence of congenital varicella syndrome (CVS) or mal- formations consistent with it.

Inactivated poliovirus vaccine is not routinely recommended for adults living in the United States; however, it is recommended for unimmunized adults in close contact with a child receiving oral polio vaccine (OPV, which is not available in United States) or who have an increased risk of exposure to OPV or wild poliovirus. Hepatitis A (inactivated) and hepatitis B (recombinant surface antigen) vaccines can be used in pregnancy for pre- and postexposure in women at risk of infection.

The indications for rabies vaccine (killed virus) are not altered by pregnancy. There also seems to be no increased risk to the embryo or fetus from vaccination within 30 days of conception with quadrivalent human papillomavirus (HPV) recombinant vaccine. But if pregnancy is detected, ACOG suggests delaying completion of the three-dose vaccination schedule until after the pregnancy (Committee Opinion, No. 344, September 2006).

The ACOGconsiders vaccination with inactivated influenza vaccine to be an essential element of prenatal care (Committee Opinion, No. 305, November 2004). The vaccine can be given at any time during pregnancy, but the intranasal influenza vaccine, a live attenuated virus preparation, should not be used in pregnancy.

Excretion of live viruses from vaccines into breast milk may occur. There is a report of tertiary contact vaccinia transmission for smallpox vaccine from a mother to her nursing infant. The effects of the other live virus vaccines on a nursing infant are unknown, but the risk of adverse effects seems to be low. Vaccines that do not contain live viruses probably carry no risk to the infant.

There are pregnancy registries for four vaccines. Health care professionals should report exposures of pregnant women to the appropriate registry: hepatitis B vaccine (800-670-6126); HPV vaccine (800-986-8999); meningococcal vaccine (800-822-2463); and varicella vaccine (800-986-8999).

Vaccines have arguably saved more lives and prevented more diseases than any other class of drug. The American College of Obstetricians and Gynecologists states that vaccination before conception is preferred to vaccination during pregnancy, but the benefits of immunization to the pregnant woman usually outweigh the theoretical risks (Committee Opinion, No. 282, January 2003). Only vaccines recommended for adults of reproductive age are discussed here.

Vaccines are classified as bacterial or viral; whole (killed, inactivated, or live attenuated); or partial microorganisms that can induce antibody formation. Although vaccines can cause infections of the embryo or fetus, and pregnant women should be informed of the presence of live organisms if they are given a live attenuated virus vaccine, there is no convincing evidence that any vaccine, bacterial or viral, has caused fetal or embryonic harm. Theoretically, however, live attenuated bacterial or viral vaccines could cause disseminated infection in pregnant patients with impaired immunity, such as those with HIV or AIDS.

Indications for two bacterial vaccines (both capsular polysaccharide-quadrivalent meningococcal and polyvalent pneumococcal) are not altered by pregnancy. Vaccinating a pregnant woman with the live attenuated BCG vaccine is not recommended, but may be indicated if the woman works in a setting where many patients are infected with resistant strains of TB.

There are two typhoid vaccines available. The oral live attenuated virus vaccine is not advised during pregnancy, except when the mother's in continued, close exposure or travels to typhoid-endemic areas. The capsular polysaccharide intramuscular vaccine should be safer in pregnancy because it does not contain live bacteria.

Live attenuated virus vaccines are normally contraindicated in pregnant women because of the known or potential risks from the wild viruses. These include influenza intranasal, measles, mumps, rubella, smallpox, varicella, and yellow fever. Vaccinating in the postpartum period or avoiding conception for at least 30 days after inoculation are two strategies to avoid exposure during pregnancy.

A live attenuated virus vaccine may be indicated in pregnancy under special circumstances. For example, because the risk of fetal vaccinia is low, smallpox vaccine is recommended for pregnant women exposed to smallpox or monkeypox. Yellow fever vaccine also should be given in pregnancy if exposure is unavoidable.

Rubella infection early in gestation causes congenital rubella syndrome. Over a 10-year period, nearly 700 pregnant women were given rubella vaccine. There was no evidence of embryonic/fetal adverse effects, but subclinical infection was found in 2% of the infants from susceptible mothers. A woman given the vaccine 3 weeks after conception had documented embryonic/fetal infection throughout gestation but still delivered a healthy infant.

Though contraindicated, varicella vaccine may present less risk to the embryo and fetus than from infection with the wild virus. In a pregnancy registry of more than 800 women who had been vaccinated within 3 months of or anytime during pregnancy, there was no evidence of congenital varicella syndrome (CVS) or mal- formations consistent with it.

Inactivated poliovirus vaccine is not routinely recommended for adults living in the United States; however, it is recommended for unimmunized adults in close contact with a child receiving oral polio vaccine (OPV, which is not available in United States) or who have an increased risk of exposure to OPV or wild poliovirus. Hepatitis A (inactivated) and hepatitis B (recombinant surface antigen) vaccines can be used in pregnancy for pre- and postexposure in women at risk of infection.

The indications for rabies vaccine (killed virus) are not altered by pregnancy. There also seems to be no increased risk to the embryo or fetus from vaccination within 30 days of conception with quadrivalent human papillomavirus (HPV) recombinant vaccine. But if pregnancy is detected, ACOG suggests delaying completion of the three-dose vaccination schedule until after the pregnancy (Committee Opinion, No. 344, September 2006).

The ACOGconsiders vaccination with inactivated influenza vaccine to be an essential element of prenatal care (Committee Opinion, No. 305, November 2004). The vaccine can be given at any time during pregnancy, but the intranasal influenza vaccine, a live attenuated virus preparation, should not be used in pregnancy.

Excretion of live viruses from vaccines into breast milk may occur. There is a report of tertiary contact vaccinia transmission for smallpox vaccine from a mother to her nursing infant. The effects of the other live virus vaccines on a nursing infant are unknown, but the risk of adverse effects seems to be low. Vaccines that do not contain live viruses probably carry no risk to the infant.

There are pregnancy registries for four vaccines. Health care professionals should report exposures of pregnant women to the appropriate registry: hepatitis B vaccine (800-670-6126); HPV vaccine (800-986-8999); meningococcal vaccine (800-822-2463); and varicella vaccine (800-986-8999).